These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12586446)

  • 1. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.
    Singewald N; Salchner P; Sharp T
    Biol Psychiatry; 2003 Feb; 53(4):275-83. PubMed ID: 12586446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.
    Singewald N; Sharp T
    Neuroscience; 2000; 98(4):759-70. PubMed ID: 10891619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of anxiogenic-induced c-Fos in the forebrain regions of developing rats.
    Kurumaji A; Umino A; Tanami M; Ito A; Asakawa M; Nishikawa T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1161-8. PubMed ID: 14523628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.
    Thompson BL; Rosen JB
    Neuropharmacology; 2006 Jan; 50(1):57-68. PubMed ID: 16185722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network.
    Johnson PL; Samuels BC; Fitz SD; Federici LM; Hammes N; Early MC; Truitt W; Lowry CA; Shekhar A
    Physiol Behav; 2012 Dec; 107(5):733-42. PubMed ID: 22554617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala.
    Hale MW; Johnson PL; Westerman AM; Abrams JK; Shekhar A; Lowry CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1285-93. PubMed ID: 20647026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus.
    Gaszner B; Kormos V; Kozicz T; Hashimoto H; Reglodi D; Helyes Z
    Neuroscience; 2012 Jan; 202():283-99. PubMed ID: 22178610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats.
    Salomé N; Salchner P; Viltart O; Sequeira H; Wigger A; Landgraf R; Singewald N
    Biol Psychiatry; 2004 Apr; 55(7):715-23. PubMed ID: 15039000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms.
    Veening JG; Böcker KB; Verdouw PM; Olivier B; De Jongh R; Groenink L
    Neuroscience; 2009 Nov; 163(4):1046-60. PubMed ID: 19580851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus.
    Compaan JC; Groenink L; van der Gugten J; Maes RA; Olivier B
    Eur J Neurosci; 1996 Nov; 8(11):2340-7. PubMed ID: 8950098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Fos immunoreactivity labeling in rat forebrain metabolic loci by caudal fourth ventricular infusion of the monocarboxylate transporter inhibitor, alpha-cyano-4-hydroxycinnamic acid.
    Briski KP; Patil GD
    Neuroendocrinology; 2005; 82(1):49-57. PubMed ID: 16401911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala.
    Sullivan GM; Apergis J; Gorman JM; LeDoux JE
    Biol Psychiatry; 2003 May; 53(10):863-70. PubMed ID: 12742673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior.
    Salchner P; Sartori SB; Sinner C; Wigger A; Frank E; Landgraf R; Singewald N
    Neuropharmacology; 2006 Jun; 50(8):1048-58. PubMed ID: 16620881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural populations in the rat forebrain and brainstem activated by the suckling stimulus as demonstrated by cFos expression.
    Li C; Chen P; Smith MS
    Neuroscience; 1999; 94(1):117-29. PubMed ID: 10613502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burst stimulation of the medial forebrain bundle selectively increase Fos-like immunoreactivity in the limbic forebrain of the rat.
    Chergui K; Nomikos GG; Mathé JM; Gonon F; Svensson TH
    Neuroscience; 1996 May; 72(1):141-56. PubMed ID: 8730713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anxiogenic drug yohimbine activates central viscerosensory circuits in rats.
    Myers EA; Banihashemi L; Rinaman L
    J Comp Neurol; 2005 Nov; 492(4):426-41. PubMed ID: 16228990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Green odor" inhalation by rats down-regulates stress-induced increases in Fos expression in stress-related forebrain regions.
    Ito A; Miyoshi M; Ueki S; Fukada M; Komaki R; Watanabe T
    Neurosci Res; 2009 Oct; 65(2):166-74. PubMed ID: 19563846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol-induced Fos immunoreactivity in the extended amygdala and hypothalamus of the rat brain: focus on cholinergic interneurons of the nucleus accumbens.
    Herring BE; Mayfield RD; Camp MC; Alcantara AA
    Alcohol Clin Exp Res; 2004 Apr; 28(4):588-97. PubMed ID: 15100610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.